Suppr超能文献

血管内皮生长因子在信号转导和疾病中的作用:超越发现和开发。

VEGF in Signaling and Disease: Beyond Discovery and Development.

机构信息

Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.

IGM Biosciences, Mountain View, CA, USA.

出版信息

Cell. 2019 Mar 7;176(6):1248-1264. doi: 10.1016/j.cell.2019.01.021.

Abstract

The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our understanding of vasculogenesis and angiogenesis during development and physiological homeostasis. Over a short span of two decades, our understanding of the molecular mechanisms by which VEGF coordinates neurovascular homeostasis has become more sophisticated. The central role of VEGF in the pathogenesis of diverse cancers and blinding eye diseases has also become evident. Elucidation of the molecular regulation of VEGF and the transformative development of multiple therapeutic pathways targeting VEGF directly or indirectly is a powerful case study of how fundamental research can guide innovation and translation. It is also an elegant example of how agnostic discovery and can transform our understanding of human disease. This review will highlight critical nodal points in VEGF biology, including recent developments in immunotherapy for cancer and multitarget approaches in neovascular eye disease.

摘要

血管内皮衍生生长因子(VEGF)的发现彻底改变了我们对发育和生理稳态过程中血管发生和血管生成的理解。在短短二十年的时间里,我们对 VEGF 协调神经血管稳态的分子机制的理解变得更加复杂。VEGF 在多种癌症和致盲眼病发病机制中的核心作用也变得明显。阐明 VEGF 的分子调控以及直接或间接靶向 VEGF 的多种治疗途径的变革性发展是基础研究如何指导创新和转化的一个有力案例。它也是一个很好的例子,说明了无偏见的发现如何改变我们对人类疾病的认识。本综述将重点介绍 VEGF 生物学中的关键节点,包括癌症免疫治疗的最新进展和新生血管性眼病的多靶点方法。

相似文献

1
VEGF in Signaling and Disease: Beyond Discovery and Development.
Cell. 2019 Mar 7;176(6):1248-1264. doi: 10.1016/j.cell.2019.01.021.
2
Molecular mechanism of VEGF and its role in pathological angiogenesis.
J Cell Biochem. 2022 Dec;123(12):1938-1965. doi: 10.1002/jcb.30344. Epub 2022 Oct 26.
3
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Oncologist. 2015 Jun;20(6):660-73. doi: 10.1634/theoncologist.2014-0465. Epub 2015 May 22.
5
Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine.
Integr Cancer Ther. 2018 Sep;17(3):582-601. doi: 10.1177/1534735418775828. Epub 2018 May 28.
6
Vascular endothelial growth factor control mechanisms in skeletal growth and repair.
Dev Dyn. 2017 Apr;246(4):227-234. doi: 10.1002/dvdy.24463. Epub 2016 Dec 29.
8
The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
Mol Biol Rep. 2020 Jun;47(6):4681-4690. doi: 10.1007/s11033-020-05470-y. Epub 2020 Jun 2.
10
VEGF-Virus Interactions: Pathogenic Mechanisms and Therapeutic Applications.
Cells. 2024 Nov 4;13(21):1815. doi: 10.3390/cells13211815.

引用本文的文献

1
Transcription factor ETV1 promotes angiogenesis after myocardial infarction via activation of the VEGFA/VEGFR2/eNOS pathway.
Front Cardiovasc Med. 2025 Aug 15;12:1633438. doi: 10.3389/fcvm.2025.1633438. eCollection 2025.
3
Exploring the effects of capsule in microcirculatory dysfunction model rats through laser speckle contrast imaging and metabolomics.
Front Pharmacol. 2025 Aug 11;16:1647514. doi: 10.3389/fphar.2025.1647514. eCollection 2025.
6
The ATF4-glutamine axis: a central node in cancer metabolism, stress adaptation, and therapeutic targeting.
Cell Death Discov. 2025 Aug 19;11(1):390. doi: 10.1038/s41420-025-02683-7.
7
A mechanistic computational model of HGF-VEGF-mediated endothelial cell proliferation and vascular permeability.
iScience. 2025 Jul 24;28(8):113199. doi: 10.1016/j.isci.2025.113199. eCollection 2025 Aug 15.
9
Glucocorticoids induce femoral head necrosis in rats through the HIF-1α/VEGF signaling pathway.
Sci Rep. 2025 Aug 9;15(1):29205. doi: 10.1038/s41598-025-15018-4.
10
Plasma levels of the lymphangiogenic factors VEGF-C, VEGF-D, and CXCL-12 are elevated in advanced diabetic nephropathy.
Ren Fail. 2025 Dec;47(1):2536196. doi: 10.1080/0886022X.2025.2536196. Epub 2025 Aug 7.

本文引用的文献

3
Combinations of Bevacizumab With Cancer Immunotherapy.
Cancer J. 2018 Jul/Aug;24(4):193-204. doi: 10.1097/PPO.0000000000000327.
4
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors.
Cancer Chemother Pharmacol. 2018 Aug;82(2):339-351. doi: 10.1007/s00280-018-3622-8. Epub 2018 Jun 15.
6
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4.
8
VEGF/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant models.
JCI Insight. 2018 May 17;3(10). doi: 10.1172/jci.insight.120231.
9
Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.
Int J Mol Sci. 2018 Apr 18;19(4):1232. doi: 10.3390/ijms19041232.
10
Gene Therapy for Retinal Degeneration.
Cell. 2018 Mar 22;173(1):5. doi: 10.1016/j.cell.2018.03.021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验